MARKET

CSTL

CSTL

Castle Biosciences
NASDAQ
38.64
-0.98
-2.47%
After Hours: 38.64 0 0.00% 17:01 12/05 EST
OPEN
39.54
PREV CLOSE
39.62
HIGH
40.10
LOW
38.38
VOLUME
549.83K
TURNOVER
--
52 WEEK HIGH
40.61
52 WEEK LOW
14.59
MARKET CAP
1.13B
P/E (TTM)
-85.2604
1D
5D
1M
3M
1Y
5Y
1D
Castle Biosciences CEO Derek J. Maetzold Reports Sale of Common Shares
Reuters · 2d ago
Castle Biosciences CEO Derek J. Maetzold Reports Sale of Common Shares
Reuters · 5d ago
Weekly Report: what happened at CSTL last week (1124-1128)?
Weekly Report · 6d ago
Castle Biosciences CEO Derek J. Maetzold Reports Disposal of Common Shares
Reuters · 11/26 19:59
SNY & REGN's Dupixent Gets EU Nod for Chronic Spontaneous Urticaria
NASDAQ · 11/25 15:45
Castle Biosciences Chief Commercial Officer Tobin W. Juvenal Reports Disposal of Common Shares
Reuters · 11/24 21:24
FDA Approves MRK's Keytruda & Keytruda SC Combo in Bladder Cancer
NASDAQ · 11/24 15:50
Weekly Report: what happened at CSTL last week (1117-1121)?
Weekly Report · 11/24 09:55
More
About CSTL
Castle Biosciences, Inc. is a molecular diagnostics company offering test solutions to aid clinicians in the diagnosis and treatment of dermatologic cancers, Barrett’s esophagus (BE), uveal melanoma (UM), and in the treatment of mental health conditions. The Company offers five commercially available proprietary multi-analyte assays with algorithmic analysis (MAAA) tests for use in the fields of dermatology, gastroenterology and ophthalmology. It also offers a proprietary pharmacogenomic (PGx) test to guide optimal drug treatment for patients diagnosed with depression, anxiety and other mental health conditions. Its products include DecisionDx-Melanoma, DecisionDx-SCC, MyPath Melanoma, TissueCypher, IDgenetix, and DecisionDx-UM. DecisionDx-SCC is its proprietary gene expression profile (GEP) test for use in patients with cutaneous squamous cell carcinoma (SCC). It also focused on chronic acid reflux related diseases, including esophageal cancer.

Webull offers Castle Biosciences Inc stock information, including NASDAQ: CSTL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CSTL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CSTL stock methods without spending real money on the virtual paper trading platform.